Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
US7045550B2 · kind B2 · utility
5Cited by
30References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 7, 2002 |
| Grant date | May 16, 2006 |
| Priority date | — |
| Expiry date | Dec 7, 2022 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB82Y5/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Polyamine effectors are administered locally to provide protection against the adverse side-effects of chemotherapy or radiation therapy, such as alopecia, mucositis and dermatitis. Pharmaceutical preparations comprising one or more polyamine effectors formulated for topical or local delivery to epithelial or mucosal cells are disclosed. Methods of administering the pharmaceutical preparations are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.